/

Other

/

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

Verified Nov 2026

Other

·

India flag

Hyderabad, Telangana

·

Since 1984

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical manufacturer headquartered in Hyderabad, founded in 1984. The company employs 10,000–50,000 people and generates $1–5 billion in annual revenue. It produces generic formulations, active pharmaceutical ingredients, and specialty medicines across oncology, cardiology, and other therapeutic areas, serving over half a billion patients in 66 countries. In September 2025, the company acquired Stugeron, an anti-vertigo brand, from Johnson & Johnson.

Dr. Reddy's Laboratories

Verified Nov 2026

AT A GLANCE

Founded

1984

Headquarters

India flag

Hyderabad, Telangana

Employees

10,000-50,000

Ownership

Dr. Reddy's Laboratories at a glance

Revenue

$1-5B

Est. band

Employees

10,000-50,000

Founded

1984

Headquarters

Hyderabad, Telangana

Import activity

5332

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

5332

Named foreign suppliers

50

Top origins

India · Oman · Sri Lanka · Italy

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Dr. Reddy's Laboratories.

What this tells a buyer

Dr. Reddy's received approximately 5,332 pharmaceutical shipments, with originating points spanning India, China, Italy, Oman, Sri Lanka, and 14 other countries across four continents.

The company manufactures over 190 medications, 60 active pharmaceutical ingredients including highly potent APIs, and develops oncology biosimilar therapies.

Dr. Reddy's is a publicly traded multinational with a market capitalization exceeding $13.5 billion and significant market presence across North America, Europe, India, and emerging markets.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

42 years in operation (founded 1984).

5,332 US import shipments on record.

Overview

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical manufacturer headquartered in Hyderabad, founded in 1984. The company employs 10,000–50,000 people and generates $1–5 billion in annual revenue. It produces generic formulations, active pharmaceutical ingredients, and specialty medicines across oncology, cardiology, and other therapeutic areas, serving over half a billion patients in 66 countries. In September 2025, the company acquired Stugeron, an anti-vertigo brand, from Johnson & Johnson.

At a glance

Attribute

Detail

Founded

1984

Headquarters

Hyderabad, Telangana

Employees

10,000-50,000

Revenue

$1-5B (estimated)

What Dr. Reddy's Laboratories makes

The company manufactures over 190 medications, 60 active pharmaceutical ingredients including highly potent APIs, and develops oncology biosimilar therapies.

Trade and customs footprint

Dr. Reddy's received approximately 5,332 pharmaceutical shipments, with originating points spanning India, China, Italy, Oman, Sri Lanka, and 14 other countries across four continents. US customs bill-of-lading records list 5332 inbound shipments across 50 foreign suppliers, with top origins including India · Oman · Sri Lanka · Italy.

Latest developments

Company details

Dr. Reddy's is a publicly traded multinational with a market capitalization exceeding $13.5 billion and significant market presence across North America, Europe, India, and emerging markets. Dr. Reddy's Laboratories was founded in 1984, has an estimated 10,000-50,000 employees, and is headquartered in Hyderabad, Telangana. On the LightSource stability read it is rated "Established & active": 42 years in operation (founded 1984). 5,332 US import shipments on record.

Frequently asked questions

What does Dr. Reddy's Laboratories do?

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical manufacturer headquartered in Hyderabad, founded in 1984. The company employs 10,000–50,000 people and generates $1–5 billion in annual revenue. It produces generic formulations, active pharmaceutical ingredients, and specialty medicines across oncology, cardiology, and other therapeutic areas, serving over half a billion patients in 66 countries. In September 2025, the company acquired Stugeron, an anti-vertigo brand, from Johnson & Johnson.

Where is Dr. Reddy's Laboratories headquartered?

Dr. Reddy's Laboratories is headquartered in Hyderabad, Telangana.

When was Dr. Reddy's Laboratories founded?

Dr. Reddy's Laboratories was founded in 1984.

How big is Dr. Reddy's Laboratories?

Dr. Reddy's Laboratories has an estimated 10,000-50,000 employees, with revenue in the $1-5B range (estimated).

Does Dr. Reddy's Laboratories import from overseas suppliers?

US customs bill-of-lading records show 5332 inbound shipments for Dr. Reddy's Laboratories, with top origins including India · Oman · Sri Lanka · Italy.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Hyderabad, Telangana (HQ)Headquarters · Telangana, India
Hyderabad, Telangana (HQ)Hyderabad, Telangana, IndiaHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.